MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer
Translational Oncology · 2025-05 · 55 · 102367
DOI: 10.1016/j.tranon.2025.102367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2025-05. Verfasst von Gloria Ravegnini und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna, Italy; Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Univer…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Ministero della Salute.
Abstract (Originalsprache)
BACKGROUND: Endometriosis (EMS) is a chronic, gynecological condition affecting 6-10 % of reproductive-age women. While these lesions are benign, ovarian EMS presents cancer-like features, and can progress to endometriosis-correlated ovarian cancer (ECOC) through a multistep process. Given the regulatory role of miRNAs in gene expression and biological pathways, we aimed to identify miRNAs associated with the malignant transformation of ovarian EMS, which could serve as a potential diagnostic tool for the early identification of such patients. METHODS: Global miRNA profiling was performed in 8 patients with benign ovarian EMS (EMS-b) and 29 patients with ECOC. Differential expression analysis (DEA) of miRNAs between EMS-b, EMS tissues from patients with ECOC (EMS-k) and ECOC tissues was performed. Receiver Operating Characteristic (ROC) curves were built to evaluate the binary classification performance of significant miRNAs. RESULTS: Comparison between EMS-b and EMS-k revealed 13 significantly deregulated miRNAs. Furthermore, when comparing ECOC and EMS-b, we observed significant deregulation of 181 miRNAs. ROC analysis revealed a panel of seven upregulated miRNAs with accuracies above 0.7 in identifying EMS-k and EMS-b. Notably, four miRNAs (hsa-miR-200a-3p, hsa-miR-141-3p, hsa-miR-183-5p, hsa-miR-10a-5p) were consistently upregulated in both EMS-k and ECOC tissues, achieving accuracies above 0.77 in distinguishing between EMS-k and EMS-b. When used to distinguish between EMS-b and ECOC tissues, these miRNAs showed accuracies even higher, above 0.94. Specifically, hsa-miR-183-5p had an accuracy of 1, hsa-miR-200a-3p and hsa-miR-141-3p of 0.97, while hsa-miR-10a-5p of 0.95. CONCLUSIONS: Our study identified a panel of miRNA biomarkers that may serve as potential candidates for the early detection of ECOC in patients previously diagnosed with ovarian EMS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna, Italy; Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy.
- Department of Morpho-functional sciences, University of Medicine and Pharmacy "Iuliu Hațieganu", Cluj-Napoca, Romania.
- Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: giulia.mantovani18@unibo.it.
- Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
- Department of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna, Italy; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Förderung
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Ministero della Salute
Zitieren
APA
Ravegnini, G., Coadă, C. A., Mantovani, G., De Leo, A., de Biase, D., Costantino, A., Gorini, F., Dondi, G., Di Costanzo, S., Mezzapesa, F., Giorgi, F. M., Tallini, G., Angelini, S., Astolfi, A., Strigari, L., De Iaco, P., & Perrone, A. M. (2025). MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer. Translational Oncology, 55, 102367. https://doi.org/10.1016/j.tranon.2025.102367
Vancouver
Ravegnini G, Coadă CA, Mantovani G, De Leo A, de Biase D, Costantino A, et al. MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer. Translational Oncology. 2025;55:102367. doi:10.1016/j.tranon.2025.102367
BibTeX
@article{Ravegnini2025,
author = {Ravegnini, Gloria and Coadă, Camelia Alexandra and Mantovani, Giulia and De Leo, Antonio and de Biase, Dario and Costantino, Alessia and Gorini, Francesca and Dondi, Giulia and Di Costanzo, Stella and Mezzapesa, Francesco and Giorgi, Federico Manuel and Tallini, Giovanni and Angelini, Sabrina and Astolfi, Annalisa and Strigari, Lidia and De Iaco, Pierandrea and Perrone, Anna Myriam},
title = {MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer},
journal = {Translational Oncology},
year = {2025},
volume = {55},
pages = {102367},
doi = {10.1016/j.tranon.2025.102367}
}
EUVIMED